KRT19, as a serum tumor marker for breast cancer, is mainly localized in the cytoskeleton and cytosol in cells (Figure S1B), which is currently more widely used in the early diagnosis of BRCA [4]. This evidence concerns the gene KRT19 and neoplasm.